"Genetic Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.
| Descriptor ID |
D005818
|
| MeSH Number(s) |
E05.393.420
|
| Concept/Terms |
Genetic Engineering- Genetic Engineering
- Genetic Intervention
- Intervention, Genetic
- Genetic Interventions
- Interventions, Genetic
- Engineering, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Genetic Engineering".
Below are MeSH descriptors whose meaning is more specific than "Genetic Engineering".
This graph shows the total number of publications written about "Genetic Engineering" by people in this website by year, and whether "Genetic Engineering" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 1 | 4 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 2 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 5 | 5 |
| 2006 | 0 | 4 | 4 |
| 2007 | 4 | 3 | 7 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 2 | 2 |
| 2013 | 4 | 1 | 5 |
| 2014 | 1 | 2 | 3 |
| 2016 | 1 | 3 | 4 |
| 2017 | 3 | 3 | 6 |
| 2018 | 0 | 4 | 4 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genetic Engineering" by people in Profiles.
-
Engineered Membrane Vesicle Production via oprF or oprI Deletion Has Distinct Phenotypic Effects in Pseudomonas putida. ACS Synth Biol. 2025 Jul 18; 14(7):2739-2752.
-
Designing live bacterial therapeutics for cancer. Adv Drug Deliv Rev. 2025 Jun; 221:115579.
-
Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements. Nat Commun. 2024 Mar 07; 15(1):2096.
-
Genetic Engineering of Resident Bacteria in the Gut Microbiome. J Bacteriol. 2023 07 25; 205(7):e0012723.
-
Engineered yeast tune down gut inflammation. Nat Med. 2021 Jul; 27(7):1150-1151.
-
Dissection of the Fgf8 regulatory landscape by in vivo CRISPR-editing reveals extensive intra- and inter-enhancer redundancy. Nat Commun. 2021 01 19; 12(1):439.
-
The COMET toolkit for composing customizable genetic programs in mammalian cells. Nat Commun. 2020 02 07; 11(1):779.
-
A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):563-572.
-
The L-platform/L-scaffold framework: a blueprint for RNA-cleaving nucleic acid enzyme design. RNA. 2020 02; 26(2):111-125.
-
Streamlined Genetic Manipulation of Diverse Bacteroides and Parabacteroides Isolates from the Human Gut Microbiota. mBio. 2019 08 13; 10(4).